Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System.
Vaccines (Basel). 2023 Mar 31;11(4):771. doi: 10.3390/vaccines11040771.
Vaccines (Basel). 2023.
PMID: 37112683
Free PMC article.
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago.
Qiang M, Ma P, Li Y, Liu H, Harding A, Min C, Wang F, Liu L, Yuan M, Ji Q, Tao P, Shi X, Li Z, Li T, Wang X, Zhang Y, Wu NC, Lee CD, Zhu X, Gilbert-Jaramillo J, Zhang C, Saxena A, Huang X, Wang H, James W, Dwek RA, Wilson IA, Yang G, Lerner RA.
Qiang M, et al.
Adv Sci (Weinh). 2022 Jan;9(1):e2102181. doi: 10.1002/advs.202102181. Epub 2021 Oct 29.
Adv Sci (Weinh). 2022.
PMID: 34716683
Free PMC article.
Item in Clipboard
EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations.
Liu Y, Chen Y, Dang L, Liu Y, Huang S, Wu S, Ma P, Jiang H, Li Y, Pan Y, Wei Y, Ma X, Liu M, Ji Q, Chi T, Huang X, Wang X, Zhou F.
Liu Y, et al.
Mol Cancer. 2021 Dec 2;20(1):157. doi: 10.1186/s12943-021-01456-x.
Mol Cancer. 2021.
PMID: 34856977
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite